Transthoracic echocardiography of hypertrophic cardiomyopathy in adults: a practical guideline from the British Society of Echocardiography

in Echo Research and Practice
View More View Less
  • 1 L Turvey, Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom of Great Britain and Northern Ireland
  • 2 D Augustine, Cardiology, Royal United Hospital Bath, Bath, United Kingdom of Great Britain and Northern Ireland
  • 3 S Robinson, Echocardiography, North West Anglia NHS Foundation Trust, Peterborough, PE3 9GZ, United Kingdom of Great Britain and Northern Ireland
  • 4 D Oxborough, Research Institute for Sports and Exercise Physiology, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom of Great Britain and Northern Ireland
  • 5 M Stout, School of Healthcare Science, Manchester Metropolitan University, Manchester, M1 5GD, United Kingdom of Great Britain and Northern Ireland
  • 6 N Smith, Cardiology, University Hospital Birmingham and University of Birmingham, Birmingham, B152TH, United Kingdom of Great Britain and Northern Ireland
  • 7 A Harkness, Cardiology Department, Colchester Hospital NHS Trust, Colchester, United Kingdom of Great Britain and Northern Ireland
  • 8 L Williams, Cardiology, Papworth Hospital, Cambridge, CB23 3RE, United Kingdom of Great Britain and Northern Ireland
  • 9 R Steeds, Cardiology, University Hospital Birmingham and University of Birmingham, Birmingham, United Kingdom of Great Britain and Northern Ireland
  • 10 W Bradlow, Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, United Kingdom of Great Britain and Northern Ireland

Correspondence: William Bradlow, Email: willbradlow@gmail.com

Hypertrophic cardiomyopathy (HCM) is common, inherited and characterised by unexplained thickening of the myocardium. The British Society of Echocardiography (BSE) has recently published a minimum dataset for transthoracic echocardiography detailing the core views needed for a standard echocardiogram. For patients with confirmed or suspected HCM, additional views and measurements are necessary. This guideline, therefore, supplements the minimum dataset and describes a tailored, stepwise approach to the echocardiographic examination, and echocardiography’s position in the diagnostic pathway, before advising on the imaging of disease complications and invasive treatments.

 

    British Society of Echocardiography